STEPHANIE GRANT-WHITNEY: Open Payments
NPI 1790460756 · HINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 46 payments from 9 companies in 2025. Trend: 2023 $680 · 2024 $1,515 · 2025 $1,510
Food & beverage: $1,482Education: $27
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $304 |
| Vanda Pharmaceuticals Inc. | 9 | $283 |
| Otsuka America Pharmaceutical, Inc. | 9 | $277 |
| Axsome Therapeutics, Inc. | 8 | $259 |
| ABBVIE INC. | 4 | $196 |
| Supernus Pharmaceuticals, Inc. | 4 | $74 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Vertical Pharmaceuticals, LLC | 2 | $41 |
| Tris Pharma Inc | 1 | $25 |
Products named: CAPLYTA, FANAPT, REXULTI, Auvelity, VRAYLAR, Qelbree, Jornay PM, Relexxii.
Industry payments across MA — which companies pay providers there.
